Imagine a patient with Crohn's disease—after months of flares, they are finally in clinical remission. Their biomarkers are stable, their pain has subsided, and their doctors are satisfied. They are ...

Researchers at the Earlham Institute, the University of Edinburgh and Heriot-Watt University analyzed gut cells to understand ...

Action Sports Jax’s Stuart Webber will be emceeing the Crohn’s & Colitis Take Steps! walk on Saturday, April 18.

Patients with IBD may experience increased serum levels of vitamin D with supplementation, but improvement in disease ...

A global meta-analysis finds that anemia affects 37% of patients with inflammatory bowel disease, highlighting gaps in ...

Analyst Faisal Khurshid applauded Abivax's obefazimod, an oral drug developed to treat moderately to severely active ...

The Crown Heights Crohns and Colitis Support will feature a leading physician, Dr. Michael Dolinger, who has revolutionized IBD care.

Researchers have used advanced genetic sequencing on a Brisbane family to identify a gene mutation linked to ulcerative colitis, a type of inflammatory bowel condition, sparking hopes of new ...

Detailed price information for Healwell AI Inc A Sub Vtg (HWAIF) from The Globe and Mail including charting and trades.

Colorectal cancer now leads cancer deaths in adults under 50, with cases rising since 1995. Learn when to start screening and recognize key symptoms to protect yourself.

Swollen joints, canker sores, and gallstones may all be signs that your Crohn’s disease is getting worse. Here are other symptoms to watch out for.

March 9, Everest Medicines (1952.HK) announced the commercial launch of VELSIPITY(R) (etrasimod arginine tablets) in Mainland China, highlighted by the issuance of the first prescription at The First ...